LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Mutua de Terrassa
Terrassa, EspañaPublicacións en colaboración con investigadores/as de Mutua de Terrassa (4)
2023
-
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Journal of Parkinson's disease, Vol. 13, Núm. 3, pp. 379-402
2019
-
Clinical and genetic characteristics of late-onset Huntington's disease
Parkinsonism and Related Disorders, Vol. 61, pp. 101-105
2016
2012
-
Impact of apathy on health-related quality of life in recently diagnosed Parkinson's disease: The ANIMO study
Movement Disorders, Vol. 27, Núm. 2, pp. 211-218